The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-centered adverse event reporting in clinical trials: A novel approach using ECOG-ACRIN E2211.
 
Wan Ying Tan
No Relationships to Disclose
 
Laura Cramer
No Relationships to Disclose
 
Noah Graham
No Relationships to Disclose
 
Namrata Vijayvergia
Honoraria - Guidepoint Global
Consulting or Advisory Role - Exelixis; RayzeBio; Taiho Oncology
Research Funding - Bristol-Myers Squibb/Medarex (Inst); ITM Isotope Technologies Munich (Inst); Oryzon Genomics (Inst); Puma Biotechnology (Inst); Zymeworks (Inst)
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Al Benson
Consulting or Advisory Role - Abbvie; Apexigen; Array BioPharma; Artemida Pharma; Boston Scientific; Bristol-Myers Squibb; HalioDx; HUTCHMED; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Natera; Pfizer; Samsung Bioepis; TheraBionic; Xencor
Research Funding - Amgen; Astellas Pharma; Bristol-Myers Squibb; Celgene; Elevar Therapeutics; Infinity Pharmaceuticals; ITM Solucin; MedImmune; Merck Sharp & Dohme; Rafael Pharmaceuticals; ST Pharm; SyncoreBio; Taiho Pharmaceutical; Tyme; Xencor
 
Pamela Kunz
Consulting or Advisory Role - BMS; Foundation Medicine
Research Funding - Advanced Accelerator Applications/Novartis (Inst); RayzeBio (Inst)